Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations

被引:50
作者
Hermans, C. [1 ]
de Moerloose, P. [2 ]
Fischer, K. [3 ]
Holstein, K. [4 ]
Klamroth, R. [5 ]
Lambert, T. [6 ]
Lavigne-Lissalde, G. [7 ]
Perez, R. [8 ]
Richards, M. [9 ]
Dolan, G. [10 ]
机构
[1] Clin Univ St Luc, Div Haematol, Haemostasis Thrombosis Unit, B-1200 Brussels, Belgium
[2] Hop Cantonal Univ Geneva, Unite Hemostase, Geneva, Switzerland
[3] Van Creveld Clin, Utrecht, Netherlands
[4] Univ Klin, Med Klin & Poliklin 2, Onkolog Zentrum, Hamburg, Germany
[5] Vivantes Klinikum Friedrichhain Klin Fuer Innere, Berlin, Germany
[6] CHU Kremlin Bicetre, Paris, France
[7] Grp Hosp Univ Caremeau, Lab Hematol, Nimes, France
[8] Hosp Virgen del Rocio, Seville, Spain
[9] St James Univ Hosp, Childrens Day Hosp, Paediat Haematol Dept, Leeds LS9 7TF, W Yorkshire, England
[10] Univ Nottingham Hosp, Queens Med Ctr, Nottingham NG7 2UH, England
关键词
haemarthrosis; haemophilia; recommendations; survey; RECOMBINANT FACTOR-VIII; REPLACEMENT THERAPY; ANGIOGRAPHIC EMBOLIZATION; CONTROLLED TRIAL; TARGET JOINTS; HOME THERAPY; ARTHROPATHY; SAFETY; DAMAGE; BLOOD;
D O I
10.1111/j.1365-2516.2010.02449.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute haemarthrosis is a frequent type of bleeding in individuals with haemophilia. Delayed and/or inadequate treatment can trigger a series of pathological changes within the joint, leading to a painful and disabling arthropathy. The early management of intra-articular bleeding has the potential to prevent chronic joint disease and may include a combination of factor replacement, rest, ice, rehabilitation and, in certain cases, joint aspiration. Little data are, however, available regarding the optimal management of acute haemarthrosis, especially with respect to replacement therapy and the use of adjunctive therapies (aspiration, avoidance of weight bearing and immobilization, as well as the use of anti-inflammatory medication and embolization). To provide more insight into the management of acute haemarthrosis in patients with haemophilia, a literature review was conducted. Concomitantly, current management was surveyed in 26 European haemophilia comprehensive care centres representing 15 different countries. The review highlights the need for future robust studies to better define the appropriate replacement therapy and the role of adjunctive therapies such as aspiration. The survey reveals much heterogeneity in the management of acute haemarthrosis across the EU. Within the constraints discussed, treatment recommendations are presented that reflect the literature, current practice and the clinical experience of the European Haemophilia Therapy Standardisation Board (EHTSB).
引用
收藏
页码:383 / 392
页数:10
相关论文
共 65 条
[1]  
ABILDGAARD CF, 1975, SEMIN HEMATOL, V12, P223
[2]  
Abshire TC, 2000, THROMB HAEMOSTASIS, V83, P811
[3]  
ALLAIN JP, 1979, THROMB HAEMOSTASIS, V42, P825
[4]  
ARONSTAM A, 1980, LANCET, V1, P169
[5]   LOW-DOSES OF FACTOR-VIII FOR SELECTED ANKLE BLEEDS IN SEVERE HEMOPHILIA-A [J].
ARONSTAM, A ;
WASSEF, M ;
HAMAD, Z .
BRITISH MEDICAL JOURNAL, 1982, 284 (6318) :790-790
[6]   THE IDENTIFICATION OF HIGH-RISK ELBOW HEMORRHAGES IN ADOLESCENTS WITH SEVERE HEMOPHILIA-A [J].
ARONSTAM, A ;
WASSEF, M ;
HAMAD, Z ;
ASTON, DL .
JOURNAL OF PEDIATRICS, 1981, 98 (05) :776-778
[7]  
ASHENHURST JB, 1977, BLOOD, V50, P181
[8]   Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors [J].
Astermark, J ;
Morado, M ;
Rocino, A ;
Van den Berg, HM ;
Von Depka, M ;
Gringeri, A ;
Mantovani, L ;
Garrido, RP ;
Schiavoni, M ;
Villar, A ;
Windyga, J .
HAEMOPHILIA, 2006, 12 (04) :363-371
[9]  
BANTA JV, 1975, WESTERN J MED, V122, P285
[10]   Guidelines on treatment of haemophilia in Sweden [J].
Berntorp, E .
HAEMOPHILIA, 1998, 4 (04) :425-426